GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,970,000 | +432.7% | 131,712 | +149.9% | 0.01% | +400.0% |
| Q2 2022 | $1,684,000 | -16.8% | 52,716 | -9.8% | 0.00% | 0.0% |
| Q1 2022 | $2,024,000 | +27.1% | 58,422 | +7.3% | 0.00% | +100.0% |
| Q4 2021 | $1,593,000 | +10.7% | 54,433 | -3.6% | 0.00% | 0.0% |
| Q3 2021 | $1,439,000 | -23.0% | 56,447 | +5.8% | 0.00% | 0.0% |
| Q2 2021 | $1,870,000 | -28.8% | 53,371 | -17.2% | 0.00% | 0.0% |
| Q1 2021 | $2,627,000 | -30.4% | 64,460 | -26.0% | 0.00% | -50.0% |
| Q4 2020 | $3,772,000 | -20.7% | 87,062 | +0.9% | 0.00% | -33.3% |
| Q3 2020 | $4,756,000 | -9.7% | 86,247 | +3.4% | 0.00% | -25.0% |
| Q2 2020 | $5,266,000 | +78.9% | 83,402 | +44.7% | 0.00% | +33.3% |
| Q1 2020 | $2,944,000 | -55.4% | 57,618 | -30.6% | 0.00% | -40.0% |
| Q4 2019 | $6,596,000 | +204.0% | 82,982 | +85.5% | 0.01% | +150.0% |
| Q3 2019 | $2,170,000 | -91.2% | 44,724 | -90.4% | 0.00% | -90.5% |
| Q2 2019 | $24,549,000 | +61.8% | 466,737 | +62.8% | 0.02% | +50.0% |
| Q1 2019 | $15,177,000 | +901.8% | 286,750 | +677.4% | 0.01% | +600.0% |
| Q4 2018 | $1,515,000 | -15.7% | 36,887 | -22.0% | 0.00% | 0.0% |
| Q3 2018 | $1,797,000 | -23.8% | 47,309 | -9.3% | 0.00% | 0.0% |
| Q2 2018 | $2,359,000 | -13.9% | 52,170 | -8.0% | 0.00% | -33.3% |
| Q1 2018 | $2,739,000 | +90.2% | 56,711 | +55.0% | 0.00% | +200.0% |
| Q4 2017 | $1,440,000 | -59.4% | 36,598 | -68.0% | 0.00% | -66.7% |
| Q3 2017 | $3,546,000 | +18.2% | 114,245 | +4.1% | 0.00% | 0.0% |
| Q2 2017 | $3,001,000 | -10.6% | 109,696 | +20.4% | 0.00% | 0.0% |
| Q1 2017 | $3,358,000 | +148.4% | 91,115 | -2.6% | 0.00% | +200.0% |
| Q4 2016 | $1,352,000 | +256.7% | 93,576 | +470.0% | 0.00% | – |
| Q3 2016 | $379,000 | -27.0% | 16,417 | -47.6% | 0.00% | -100.0% |
| Q2 2016 | $519,000 | +78.4% | 31,339 | +70.6% | 0.00% | – |
| Q1 2016 | $291,000 | +35.3% | 18,371 | +175.4% | 0.00% | – |
| Q4 2015 | $215,000 | -65.9% | 6,671 | -55.4% | 0.00% | -100.0% |
| Q3 2015 | $631,000 | – | 14,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |